UPDATE: Press Release: LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche Read more about UPDATE: Press Release: LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche
LabCorp Subsidiary Sequenom, Inc. Announces Expiration of and Final Tender Results for Tender Offers for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018 Read more about LabCorp Subsidiary Sequenom, Inc. Announces Expiration of and Final Tender Results for Tender Offers for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018
Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running Read more about Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Subsidiary Sequenom, Inc. Announces Early Tender Results for Tender Offers and Successful Completion of Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018 Read more about LabCorp Subsidiary Sequenom, Inc. Announces Early Tender Results for Tender Offers and Successful Completion of Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018
LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development Read more about LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development
LabCorp Subsidiary Sequenom Inc. Announces Tender Offers and Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018 Read more about LabCorp Subsidiary Sequenom Inc. Announces Tender Offers and Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
Laboratory Corporation of America® Holdings Successfully Completes Acquisition of Sequenom, Inc. Read more about Laboratory Corporation of America® Holdings Successfully Completes Acquisition of Sequenom, Inc.
LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
